The drug resistance profile of mycobacterium abscessus group strains from korea

Annals of Laboratory Medicine

Volumn 34, Issue 1, 2014, Pages 31-37

  Lee, Seung Heon ^a   Yoo, Hee Kyung ^a   Kim, Seol Hee ^a   Koh, Won Jung ^b   Kim, Chang K ^a   Park, Young Kil ^a   Kim, Hee Jin ^a  

^a Korean Institute of Tuberculosis   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Drug resistance; Mutation; Mycobacterium abscessus group

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CLARITHROMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); METHYLTRANSFERASE;

ANTIBIOTIC RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; DNA SEQUENCE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS GROUP; SOUTH KOREA;

DRUG RESISTANCE; MUTATION; MYCOBACTERIUM ABSCESSUS GROUP;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CLARITHROMYCIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; HUMANS; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS, NONTUBERCULOUS; REPUBLIC OF KOREA; SEQUENCE ANALYSIS, DNA;

EID: 84893421504     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2014.34.1.31     Document Type: Article

References (28)

1. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC, Tschen JA, Stone MS. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 1983;5:657-79
2. Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993;147:1271-8.
3. Han XY, Dé I, Jacobson KL. Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 2007;128:612-21
4. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley CL. Clinical and microbiologic outcomes in patients receiving treatment of Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011;52:565-71.
5. Jeon K, Kwon OJ, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients. Am J Respir Crit Care Med 2009;180:896-902
6. Lyu J, Jang HJ, Song JW, Choi CM, Oh YM, Lee SD, et al. Outcomes in patients with Mycobacterium abscessuss pulmonary disease treated with long-term injectable drugs. Respir Med 2011;105:781-7.
7. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease. Am J Respir Crit Care Med 2007;175:367-416
8. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8
9. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal 2008;22:415-20
10. Kim HY, Kook Y, Yun YJ, Park CG, Lee NY, Shim TS, et al. Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates. J Clin Microbiol 2008;46:3384-90
11. Nash KA, Brown-Elliott BA, Wallace RJ Jr. A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. AntimicrobAgents Chemother 2009;53:1367-76
12. Kim HY, Kim BJ, Kook Y, Yun YJ, Shin JH, Kim BJ, et al. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns. Microbiol Immunol 2010;54:347-53
13. Koh WJ, Jeon K, Lee NY, Kim BJ, Kook YH, Lee SH, et al. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus. Am J Respir Crit Care Med 2011;183:405-10.
14. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; approved Standard, M24-A2. Wayne, PA: CLSI, 2011
15. Wallace RJ Jr, Meier A, Brown BA, Zhang Y, Sander P, Onyi GO, et al. Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus. Antimicrob Agents Chemother 1996;40:1676-81
16. Nash KA and Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995;39:2635-30.
17. Prammananan T, Sander P, Brown BA, Frischkorn K, Onyi GO, Zhang Y, et al. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis 1998;177:1573-81
18. Guillemin I, Jarlier V, Cambau E. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob Agents Chemother 1998;42:2084-8.
19. Adékambi T, Berger P, Raoult D, Drancourt M. rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov. Int J Syst Evol Microbiol 2006;56:133-43
20. Adékambi T, Reynaud-Gaubert M, Greub G, Gevaudan MJ, La Scola B, Raoult D, et al. Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia. J Clin Microbiol 2004;42:5493-501.
21. Nash KA and Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995;39:2625-30.
22. Coleman K, Athalye M, Clancey A, Davison M, Payne DJ, Perry CR, et al. Bacterial resistance mechanisms as therapeutic targets. J Antimicrob Chemother 1994;33:1091-116.
23. Fierro JF, Hardisson C, Salas JA. Involvement if cell impermeability in resistance to macrolides in some producer streptomycetes. J Antibiot 1988;41:142-4
24. Banerjee SK, Bhatt K, Rana S, Misra P, Chakraborti PK. Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis. Biochem Biophys Res Commun 1996;226:362-8
25. Meier A, Heifets L, Wallace RJ Jr, Zhang Y, Brown BA, Sander P, et al. Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis 1996;174:354-60.
26. Bastian S, Veziris N, Roux AL, Brossier F, Gaillard JL, Jarlier V, et al. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother 2011;55:775-81.
27. Nessar R, Reyrat JM, Murray A, Gicquel B. Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus. J Antimicrob Chemother 2011;66:1719-24.
28. Monego F, Duarte RS, Biondo AW. gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil. Microb Drug Resist 2012;18:1-6.